7-74063224-G-T
Variant summary
Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PVS1PM2PP3_StrongPP5_Very_Strong
The NM_000501.4(ELN):c.1858G>T(p.Gly620*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000501.4 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
- cutis laxa, autosomal dominant 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
- supravalvular aortic stenosisInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- autosomal dominant cutis laxaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 22 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000501.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELN | NM_000501.4 | MANE Select | c.1858G>T | p.Gly620* | stop_gained splice_region | Exon 27 of 33 | NP_000492.2 | ||
| ELN | NM_001278939.2 | c.2044G>T | p.Gly682* | stop_gained splice_region | Exon 28 of 34 | NP_001265868.1 | |||
| ELN | NM_001278915.2 | c.1876G>T | p.Gly626* | stop_gained splice_region | Exon 27 of 33 | NP_001265844.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ELN | ENST00000252034.12 | TSL:1 MANE Select | c.1858G>T | p.Gly620* | stop_gained splice_region | Exon 27 of 33 | ENSP00000252034.7 | ||
| ELN | ENST00000380562.8 | TSL:1 | c.1876G>T | p.Gly626* | stop_gained splice_region | Exon 27 of 33 | ENSP00000369936.4 | ||
| ELN | ENST00000458204.5 | TSL:1 | c.1828G>T | p.Gly610* | stop_gained splice_region | Exon 26 of 32 | ENSP00000403162.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Supravalvar aortic stenosis Pathogenic:2
The 1858G>T (Gly620X) variant has not been previously reported and is expected t o lead to heterozygous loss of function of the Elastin (ELN) gene by one or both of the following mechanisms. It creates a premature stop codon at position 620, which is predicted to lead to either truncated or absent protein (loss of funct ion). In addition, the 1858G>T variant affects the last base of exon 27, which i s part of the splicing consensus sequence and four computational tools predict t hat it severely affects splicing. Loss of function is an established mechanism of disease for the ELN gene (Human Genome Mutation Database, HGMD), which makes it highly likely that the 1858G>T variant is pathogenic.
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ELN are known to be pathogenic (PMID: 11175284). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with ELN-related conditions. ClinVar contains an entry for this variant (Variation ID: 163397). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly682*) in the ELN gene. It is expected to result in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at